Reviva Pharmaceuticals Holdings Inc Total Liabilities

Latest as of September 2025: $9.78 Million USD

Reviva Pharmaceuticals Holdings Inc total liabilities. Based on the latest financial reports, Reviva Pharmaceuticals Holdings Inc (RVPHW) has total liabilities worth $9.78 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check RVPHW financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Reviva Pharmaceuticals Holdings Inc (2018–2024)

Total liabilities of Reviva Pharmaceuticals Holdings Inc from 2018 to 2024. This chart illustrates how Reviva Pharmaceuticals Holdings Inc's total liabilities have evolved over time, based on quarterly financial data.

Reviva Pharmaceuticals Holdings Inc Competitors by Total Liabilities

The table below lists competitors of Reviva Pharmaceuticals Holdings Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Reliance Global Group Inc NASDAQ:RELIW	USA	$8.91 Million
Prairie Lithium Limited AU:PL9	Australia	AU$4.03 Million
Future Enterprises Limited NSE:FEL	India	Rs698.17 Million
Lion Financial Group Limited NASDAQ:LGHLW	USA	$29.17 Million
Advent Technologies Holdings Inc NASDAQ:ADNWW	USA	$24.46 Million
Kardan NV TA:KRNV	Israel	ILA721.20 Million
Arko Corp NASDAQ:ARKOW	USA	$3.21 Billion
Ordinary Fully Paid Deferred Settlement AU:1TTDB	Australia	AU$243.99K

Liability Composition Analysis (2018–2024)

This chart breaks down Reviva Pharmaceuticals Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Reviva Pharmaceuticals Holdings Inc.

Liquidity & Leverage Metrics

Reviva Pharmaceuticals Holdings Inc Total Liabilities Ratios Explained

Reviva Pharmaceuticals Holdings Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.39	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.68	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Reviva Pharmaceuticals Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Reviva Pharmaceuticals Holdings Inc (2018–2024)

The table below shows the annual total liabilities of Reviva Pharmaceuticals Holdings Inc from 2018 to 2024.

Year	Total Liabilities	Change
2024-12-31	$14.69 Million	-18.30%
2023-12-31	$17.98 Million	+70.78%
2022-12-31	$10.53 Million	+287.46%
2021-12-31	$2.72 Million	-17.56%
2020-12-31	$3.30 Million	-51.62%
2019-12-31	$6.81 Million	+11.96%
2018-12-31	$6.09 Million	--

About Reviva Pharmaceuticals Holdings Inc

NASDAQ:RVPHW USA Biotechnology

Market Cap

$27.95

Market Cap Rank

#32088 Global

#6491 in USA

Share Price

$0.00

Change (1 day)

-16.67%

52-Week Range

$0.00 - $0.04

All Time High

$2.77